ACHE and Alzheimer disease: An ongoing clinical trial is investigating if EGCG positively affects the course of AD as assessed by Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in early state AD patients co-medicated with acetylcholine esterase inhibitors (ClinicalTrials.gov identifier: NCT00951834).